IPO | News Molbio Diagnostics IPO: 7 Essential Facts, Growth Drivers and Risks ByKathan Dhagai 12 August, 202612 August, 2026 Molbio Diagnostics IPO review covering its Truenat platform, financial performance, GMP, valuation, growth opportunities and key risks for investors.
